PROS1 and viral infectious disease: Indeed, the synergic effects of using peptide combinations against SARS-CoV-2 infection were previously described; however, the authors did not use peptides as antigens but explored the ability of three combined peptides to prevent the interaction between the S-protein and ACE-2 receptor, thus impairing viral infection.